• The global Dextroamphetamine Sulfate API market was valued at US$ 60.1 million in 2024 and is expected to grow at a Compound Annual Growth Rate (CAGR) of 3.9%, reaching US$ 81.2 million by 2032.
Report Studies
• The increasing prevalence of ADHD among children and adults, along with rising awareness about mental health treatment, is driving this growth.The Dextroamphetamine Sulfate API market refers to the industry involved in the production and distribution of the active pharmaceutical ingredient (API) used in medications for treating disorders such as Attention Deficit Hyperactivity Disorder (ADHD), narcolepsy, and certain forms of depression. Dextroamphetamine sulfate is a central nervous system stimulant, widely recognized for its role in increasing dopamine and norepinephrine levels in the brain, enhancing concentration, and reducing impulsivity.
Email: help@intelmarketresearch.com +91 9169164321
•Barreled
•Bags
By Applications
• Attention Deficit Hyperactivity Disorder (ADHD) • Narcolepsy • Depression
Obesity
•Ashland
•Curia Global
•Mallinckrodt Pharmaceuticals
•Siegfried
•Chattem Chemicals
